Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 541-548 , June 2006

Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level

  • Virendra Kumar

      Affiliations

    • Department of NMR, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Naranamangalam R. Jagannathan

      Affiliations

    • Department of NMR, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 2659 3253, 2658 8533; fax: +91 011 2658 8663, 2658 8641.
    • ,
  • Rajeev Kumar

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Sharat C. Das

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Lokesh Jindal

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Sanjay Thulkar

      Affiliations

    • Department of Radio-diagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Siddhartha D. Gupta

      Affiliations

    • Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Sadanand N. Dwivedi

      Affiliations

    • Department of Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Stefan Roell

      Affiliations

    • Siemens AG, Medical Solutions MR, Application Development Spectroscopy (MREA-MRS), 91050 Erlangen, Germany
    • ,
  • Ashok K. Hemal

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    • ,
  • Narmada P. Gupta

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India

Received 29 October 2005 ,Accepted 10 January 2006.

References 

  1. Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT. Molecular imaging in prostate cancer. J Cell Biochem. 2003;90:473–483
  2. Young HH. The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905. J Urol. 2002;168:914–921
  3. Coakley FV, Qayyum A, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol. 2003;170:69–75
  4. Tempany CM, Haker S. Magnetic resonance-guided prostate biopsy. In:  D'Amico V-Antony,  Loeffler S Jay,  Harris R Jay editor. Image guided diagnosis and treatment of cancer. New Jersey: Humana Press; 2003;p. 35
  5. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am. 2000;38:59–85
  6. Bartolozzi CCL, Menchi I, Ortori S, Lencioni R. Endorectal magnetic resonance imaging in local staging of prostate carcinoma. Abdom Imaging. 2001;26:111–122
  7. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer, local staging with endorectal surface coil MR imaging. Radiology. 1991;178:797–802
  8. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging, concepts and applications. J Magn Reson Imaging. 2001;13:534–546
  9. Mukherji SK, Cheneverti TL, Castillo M. Diffusion-weighted magnetic resonance imaging. J Neuroophthalmol. 2002;22:118–122
  10. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002;16:196–200
  11. Chan I, Wells W, Mulkern RV, Haker S, Zhang J, Zou KH, et al Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging, a multichannel statistical classifier. Med Phys. 2003;30:2390–2398
  12. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med. 2001;46:1054–1058
  13. Sinha S, Sinha U. In vivo diffusion tensor imaging of the human prostate. Magn Reson Med. 2004;52:530–537
  14. Kumar R, Kumar M, Jagannathan NR, Gupta NP, Hemal AK. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate. Urol Res. 2004;32:36–40
  15. Hasumi M, Suzuki K, Oya N, Ito K, Kurokawa K, Fukabori Y, et al. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Res. 2002;22:1205–1208
  16. Garcia-Segura JM, Sanchez-Chapado M, Ibarburen C, Viano J, Angulo JC, Gonzalez J, et al. In vivo proton magnetic resonance spectroscopy of diseased prostate, spectroscopic features of malignant versus benign pathology. Magn Reson Imaging. 1999;17:755–765
  17. Liney GP, Turnbull LW, Knowles AJ. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed. 1999;12:39–44
  18. Kim JK, Kim DY, Lee YH, Sung NK, Chung DS, Kim OD, et al. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia, localized proton magnetic resonance spectroscopy using external-body surface coil. Magn Reson Imaging. 1998;16:1281–1288
  19. Heerschap A, Jager GJ, van der Graaf M, Barentsz JO, Ruijs SHJ. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn Reson Med. 1997;37:204–213
  20. Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Horsman A. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging. 1997;15:1177–1186
  21. Lowry M, Liney GP, Turnbull LW, Manton DJ, Blackband SJ, Horsman A. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy, zonal and age-related differences. Magn Reson Med. 1996;36:352–358
  22. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone, detection via localized proton spectroscopy. Urology. 1995;45:459–466
  23. Schick F, Bongers H, Kurz S, Jung W, Pfeffer M, Lutz O. Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5T. Magn Reson Med. 1993;29:38–43
  24. Thomas MA, Narayan P, Kurhanewicz J, Jajodia P, Weiner MW. 1H MR spectroscopy of normal and malignant human prostates in vivo. J Magn Reson. 1990;87:610–619
  25. DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ, Sklar GN, et al. Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002;52:429–438
  26. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002;16:451–463
  27. Swanson MG, Vigneron DB, Tran TK, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Cancer Invest. 2001;19:510–523
  28. Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer, metabolic characteristics at 1H MR spectroscopic imaging — initial results. Radiology. 2003;229:241–247
  29. Walsh PC. Benign prostatic hyperplasia. In:  Walsh PC,  Gittes RF,  Perlmutter AD,  Stamey TA editor. Campbell's urology. vol. 2:Philadelphia: WB Saunders; 1986;p. 1248–1265
  30. Mescher M, Tannus A, Johnson OM, Garwood M. Solvent suppression using selective echo dephasing. J Magn Reson A. 1996;123:226–229
  31. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology. 1996;198:795–805
  32. Kumar V, Jagannathan NR, Kumar R, et al. Determination of apparent diffusion coefficient (ADC) in prostate of men with raised serum prostate specific antigen (PSA) or abnormal digital rectal examination (DRE) prior to transrectal ultrasound (TRUS) guided biopsy. [submitted for publication].
  33. Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O, et al. Differentiation of non-cancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging. 2005;21:258–262
  34. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172–178
  35. Hricak H, Dooms GC, McNeal JE, et al. MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol. 1987;148
  36. Hsing AWTL, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60–67
  37. Greenlee HRTM, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin. 2001;51:15–36
  38. National cancer registry program, consolidated report of the population based cancer registries. New Delhi, India: Indian Council of Medical Research (ICMR); 2001;
  39. Engelbrecht MR, Barentsz JO, Jager GJ, et al. Prostate cancer staging using imaging. BJU Int. 2000;86:123–134
  40. Schiebler ML, White M, Maygarden SJ, Mohler JL. In vitro high resolution 1H-spectroscopy of the human prostate, benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn Reson Med. 1993;29:285–291
  41. Costello LC, Franklin RB. The intermediary metabolism of the prostate, a key to understanding the pathogenesis and progression of prostate malignancy. Oncology. 2000;59:269–282
  42. Carter HB, Partin AW. Diagnosis and staging of prostate cancer. In:  Walsh PC editors. Campbell's urology. 8th ed.. Philadelphia: Saunders; 2002;p. 3058
  43. Cooper JF, Farid I. The role of citric acid in the physiology of the prostate. 3. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol. 1964;92:533–536
  44. Herminghaus S, Pilatus U, Moller-Hartmann W, Raab P, Lanfermann H, Schlote W, et al. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed. 2002;15:385–392

PII: S0730-725X(06)00025-7

doi: 10.1016/j.mri.2006.01.001

Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 541-548 , June 2006

Article Tools

* Image Usage & Resolution